Tag: CorPath GRX
The inevitable growth of neurovascular robotics: Improved precision today, potential remote...
This advertorial, sponsored by Siemens Healthineers, is intended for readers outside of the USA.
The majority of cases the CorPath GRX Neurovascular Robotic System (Siemens...
CorPath GRX robot demonstrates safety and effectiveness in neurovascular aneurysm treatment
Corindus, a Siemens Healthineers company, announced today the recent presentation of results from a “first-of-its-kind” study demonstrating the safety and effectiveness of robotic-assisted neurovascular...
Corindus relocates Massachusetts headquarters to accommodate company growth
Corindus, a Siemens Healthineers company, announced today the opening of its new headquarters at 275 Grove Street in Newton, USA. Siemens Healthineers relocated the...
Why robotics holds the key to the future of stroke treatment
Vitor Pereira and Nicole Cancelliere (St Michael’s Hospital, Toronto, Canada) outline recent breakthroughs in the deployment of robotics for neurointerventional procedures and discuss future...
Few cases and short timeframe required to overcome learning curve with...
A retrospective analysis of a prospectively maintained database has found that robot-assisted carotid artery stenting (CAS) is both safe and effective. Writing in Neurosurgical...
World’s first robotic-assisted aneurysm coiling has been performed using Corindus’ CorPath...
The first-in-human robotic-assisted neurovascular intervention has been performed at the Toronto Western Hospital (Toronto, Canada), by a team led by Vitor Mendes Pereira. A...
A robotic future for the neurovascular field is deemed feasible
Does the shift away from open surgical vascular procedures towards percutaneous interventions favour a rise in the use of robotics? Gavin Britz (Houston Methodist...
Corindus announces regulatory approval of CorPath GRX for neurovascular intervention in...
Corindus Vascular Robotics has announced that it received approval from the Australian Therapeutic Goods Administration to commercialise its CorPath GRX System for neurovascular interventions...
